Author:
Bangalore Sripal,Davis Barry R.,Cushman William C.,Pressel Sara L.,Muntner Paul M.,Calhoun David A.,Kostis John B.,Whelton Paul K.,Probstfield Jeffrey L.,Rahman Mahboob,Black Henry R.
Funder
Pfizer
Bristol-Myers Squibb
National Heart, Lung, and Blood Institute
AstraZeneca
Reference17 articles.
1. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research;Calhoun;Circulation,2008
2. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;Chobanian;JAMA,2003
3. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;Eur Heart J,2013
4. National Clinical Guideline Centre. The clinical management of primary hypertension in adults. Available at: http://www.nice.org.uk/guidance/index.jsp?action=download&o=53228. Accessed December 3, 2015.
5. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT);Muntner;Hypertension,2014
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献